Funding for this research was provided by:
National Institutes of Health (RF1 AG051485, R21 AG059176, RF1 AG059082)
Article History
Received: 29 November 2021
Accepted: 2 December 2022
First Online: 23 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: MC received research support from Vigil. MC is a scientific advisory board member of Vigil and has a patent to TREM2 pending.